Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization.

Published in:

2008

By:

• Kinsella TJ;
• Kinsella MT;
• Hong S;
• Johnson JP;
• Burback B;
• Tosca PJ;
• Kinsella, Timothy J;
• Kinsella, Michael T;
• Hong, Seongwon;
• Johnson, Jerry P;
• Burback, Brian;
• Tosca, Patricia J

Publication type:

journal article